Analysts Set Ventas, Inc. (NYSE:VTR) Target Price at $94.00

Ventas, Inc. (NYSE:VTR) has earned an average recommendation of “Moderate Buy” from the seventeen analysts that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $95.00.

Several research analysts recently issued reports on the stock. JPMorgan Chase & Co. increased their price target on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Monday, May 11th. Mizuho set a $98.00 price target on shares of Ventas in a research note on Friday. Scotiabank increased their price target on shares of Ventas from $93.00 to $95.00 and gave the stock a “sector perform” rating in a research note on Thursday. Royal Bank Of Canada increased their price target on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th. Finally, Wells Fargo & Company increased their price target on shares of Ventas from $88.00 to $93.00 and gave the stock an “overweight” rating in a research note on Thursday, March 26th.

Ventas Trading Up 0.2%

NYSE:VTR opened at $88.22 on Friday. The company has a 50-day moving average price of $85.32 and a 200-day moving average price of $81.82. Ventas has a 12 month low of $61.76 and a 12 month high of $91.06. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The stock has a market cap of $42.89 billion, a price-to-earnings ratio of 160.40, a P/E/G ratio of 2.16 and a beta of 0.74.

Ventas (NYSE:VTR) last issued its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The firm’s revenue was up 22.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Equities analysts predict that Ventas will post 3.86 EPS for the current year.

Ventas Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Tuesday, June 30th. Ventas’s dividend payout ratio (DPR) is presently 378.18%.

Insider Activity

In related news, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the transaction, the director directly owned 28,349 shares in the company, valued at $2,557,079.80. This trade represents a 3.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by insiders.

Institutional Trading of Ventas

Institutional investors and hedge funds have recently bought and sold shares of the company. Cloud Capital Management LLC bought a new stake in Ventas during the 3rd quarter valued at about $25,000. Dynamic Wealth Strategies LLC bought a new stake in Ventas during the 1st quarter valued at about $25,000. GoalVest Advisory LLC bought a new stake in Ventas during the 4th quarter valued at about $26,000. Wiser Advisor Group LLC bought a new stake in Ventas during the 3rd quarter valued at about $27,000. Finally, IFC & Insurance Marketing Inc. bought a new stake in Ventas during the 4th quarter valued at about $30,000. 94.18% of the stock is currently owned by institutional investors.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.